CRVS
Corvus Pharmacet (CRVS)
NASDAQ
$14.53+$0.06 (+0.45%)
Price as of Aug 21, 2026 7:36 PM EDT
  • $1.2B
    Market Cap
  • 160.54%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 26
Valuation
CRVS
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
0

Momentum Score

Score: 70
Valuation
CRVS
vs History
vs S&P 500
3-Month Momentum
18.96%
12-Month Momentum
158.60%
3-Month Risk Adjusted Momentum
86.55%
12-Month Risk Adjusted Momentum
88.89%

True Yield

N/A
Valuation
CRVS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 36
Valuation
CRVS
vs History
vs S&P 500
Ohlson's O-Score
2